Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Armour Pharmaceutical Company Patents
Assignee:
Armour Pharmaceutical Company
Address:
Tuckahoe, NY
No. of patents:
82
Patents:


1 2










Patent Number Title Of Patent Date Issued
D289548 Combined plasmapheresis console and fluid exchanger April 28, 1987
5202246 Treatment of immobilized matrices for preparation of pharmaceutical and biological products with April 13, 1993
Disclosed are methods of inactivating pyrogen producing organisms and pyrogenic substances in immobilized solid matrices which are used in the production and/or purification of biomedical and pharmaceutical products and materials by contacting the solid matrices with pyrogen inactivating
4876241 Stabilization of biological and pharmaceutical products during thermal inactivation of viral and October 24, 1989
A method of inactivating pathogens in proteinaceous biological and pharmaceutical products which comprises: mixing the product in an aqueous solution with one or more primary stabilizers selected from the group consisting of sugars and sugar alcohols and one or more secondary stabili
4758657 Method of purifying Factor VIII:C July 19, 1988
Disclosed is a process for purifying Factor VIII:C in high yield and potency from source material containing Factor VIII:C, Factor VIII:R and other plasma proteins and factors comprising the steps of: adsorbing Factor VIII:C onto a hydrophobic interaction matrix, separating unwanted
4746728 8-glycine, des-19-leucine-calcitonin May 24, 1988
New peptides are disclosed which have biological activity of the same type as the known calcitonins and which have a glycine at position 8 instead of the natural valine found in that position. In addition these new peptides do not have a leucine in position 19. The position 19 leucine is
4659804 (Bis-1,7-S-acetamidomethyl-L-cysteine)salmon calcitonin April 21, 1987
New peptides are disclosed which have biological activity of the same type as known calcitonins and which do not have a disulfide bond connecting the cysteines at positions one and seven. Also resin peptides are disclosed which may be converted to peptides having such biological activity
4639511 Des-19-leucine-calcitonin analogs January 27, 1987
New peptides are disclosed which have biological activity of the same type as known calcitonins and which do not have a leucine in position 19. The position 19 leucine is omitted. Also resin peptides are disclosed which may be converted to peptides having such biological activity; and
4639510 (1-S-acetamidomethyl cysteine, 7-alanine)calcitonin January 27, 1987
New peptides are disclosed which have biological activity of the same type as known calcitonins and which have an S-acetamidomethyl cysteine at one and an alanine at seven, or an alanine at one and an S-acetamidomethyl cysteine at seven. Also resin peptides are disclosed which may be
4639509 [16,19-Di-alanine] calcitonin January 27, 1987
New peptides are disclosed which have biological activity of the same type as known calcitonins and which have an alanine in positions 16 and 19 instead of the natural leucine or phenylalanine found in those positions. Also resin peptides are disclosed which may be converted to peptides
4622388 Des-2-serine, 3 asparagine-calcitonin November 11, 1986
New peptides are disclosed which have biological activity of the same type as known calcitonins and which do not have a serine in position 2 nor an asparagine in position 3. Both serine 2 and asparagine 3 are omitted. Also resin peptides are disclosed which may be converted to peptides h
4622386 [1,7-di-alanine]calcitonin November 11, 1986
New peptides are disclosed which have biological activity of the same type as known calcitonins and which do not have cysteines at positions one and seven. Also resin peptides are disclosed which may be converted to peptides having such biological activity; and processes for producing sa
4605515 Calcitonin-(1-23)-peptide amide August 12, 1986
New peptides ae disclosed which have biological activity of the same type as known calcitonins and contains only twenty-three amino acids rather than the normally occurring thirty-two amino acids. Also resin peptides are disclosed which may be converted to peptides having such biological
4605514 Des-4-leucine-calcitonin August 12, 1986
New peptides are disclosed which have biological activity of the same type as known calcitonins and which do not have a leucine in position 4. The position 4 leucine is omitted. Also resin peptides are disclosed which may be converted to peptides having such biological activity; and proc
4604358 Preparation of pasteurized human plasminogen August 5, 1986
This invention relates to a method for producing a plasminogen preparation which has been pasteurized to produce a hepatitis safe injectable plasminogen. The method comprises: adding to an aqueous solution of plasminogen the protective agent of methyl lysine ester, or ethyl lysine es
4604238 Analogs of calcitonin August 5, 1986
New peptides are disclosed which have biological activity of the same type as known calcitonins and which have a shorter amino acid chain than natural calcitonins and are also substitution analogs of the natural calcitonins. Also resin peptides are disclosed which may be converted to
4604237 Des-21-threonine-calcitonin August 5, 1986
New peptides are disclosed which have biological activity of the same type as known calcitonins and which do not have a threonine in position 21. The position 21 threonine is omitted. Also resin peptides are disclosed which may be converted to peptides having such biological activity; an
4528132 [16-Alanine]calcitonin July 9, 1985
New peptides are disclosed which have biological activity of the same type as known calcitonins and which have an alanine in position 16 instead of the natural leucine or phenylalanine found in that position. Also resin peptides are disclosed which may be converted to peptides having suc
4524062 Antiperspirant/deodorant stick compositions June 18, 1985
Antiperspirant/deodorant stick composition which comprises: a powdered antiperspirant agent the particles of which are enrobed in a coating material, contained in a cologne stick base.
4508709 Process for purifying factor VIII:C April 2, 1985
Factor VIII:C is purified by chromatographic absorption on aminohexyl agarose at a pH above 5.5 up to about 8, and preferably 6.5 to 7.2, and a conductivity of about 25 to about 35 mS/cm.
4497732 1A-Endo-glycine-calcitonin February 5, 1985
New peptides are disclosed which have biological activity of the same type as known calcitonins and which have a longer amino acid chain than natural calcitonins, specifically, the peptide chain of the disulfide ring is enlarged. Also resin peptides are disclosed which may be converted t
4497731 Glycine 8-des-tyrosine 22 calcitonin February 5, 1985
Two new peptides are disclosed which have biological activity of the same type as known calcitonins, which have a shorter amino acid chain than natural calcitonins and which are substitution analogs of the natural calcitonins. Also resin peptides are disclosed which may be converted to
4495097 Des-serine.sup.2 -glycine.sup.8 calcitonin January 22, 1985
Two new peptides are disclosed which have biological activity of the same type as known calcitonins and which have a shorter amino acid chain than natural calcitonins and are also substitution analogs of the natural calcitonins. Also resin peptides are disclosed which may be converted to
4486410 Heat defibrinogenation of AHF preparation December 4, 1984
Antihemophilic factor (AHF), a blood component necessary for clotting of normal whole blood, is extracted from cryoprecipitate containing AHF and fibrinogen as its principal components by: rapidly raising and thereafter lowering the temperature of the cryoprecipitate suspension to select
4478829 Pharmaceutical preparation containing purified fibronectin October 23, 1984
Disclosed are readily reconstitutable lyophilized fibronectin formulations containing fibronectin, a neutral salt, a carbohydrate and a surface active agent.
4478825 Warm ethanol method for preparation of low fibrinogen antihemophilic factor October 23, 1984
Antihemophilic factor (AHF), a blood protein component necessary for clotting of normal whole blood, is extracted and concentrated from a cryoprecipitate suspension containing AHF and fibrinogen as its principal components by: selectively precipitating fibrinogen from a water-ethanol
4469632 D-Arginine.sup.24 calcitonin September 4, 1984
New peptides are disclosed which have biological activity of the same type as known calcitonins and which have a D-amino acid in position 24 instead of the natural L-amino acid. Also resin peptides are disclosed which may be converted to peptides having such biological activity, and proc
4451395 Des-serine.sup.2 -des-tyrosine.sup.22 calcitonin May 29, 1984
Two new peptides are disclosed which have biological activity of the same type as known calcitonins and which have a shorter amino acid chain than natural calcitonins. Also resin peptides are disclosed which may be converted to peptides having such biological activity; and processes for
4444681 L-Tyrosine.sup.21 calcitonin April 24, 1984
New peptides are disclosed which have biological activity of the same type as known calcitonins and which are substitution analogs of natural calcitonins. Also resin peptides are disclosed which may be converted to peptides having such biological activity; and processes for producing sai
4434155 Basic aluminum bromide compositions and methods useful as astringents or anti-perspirants February 28, 1984
Basic aluminum bromides having a basicity of about 5/6 have been found to be readily soluble in cosmetic solvents such as anhydrous ethanol, to have a high degree of compatibility with halogenated hydrocarbons, and to have excellent astringent characteristics. These properties make the 5
4430155 Production of macrospherical particles February 7, 1984
A process and improved apparatus are provided for producing macrospherical particles. The particles themselves have increased wall thicknesses and higher densities than particles produced by conventional means and are thus not subject to deep lung penetration. The produced particles are
4422967 Purification of calcitonin by partition chromatography December 27, 1983
The purification of crude calcitonin by subjecting a crude calcitonin material to partition chromatography in which the solvent utilized is a mixture of butanol, a lower aliphatic alcohol, which is ethanol, methanol, or propanol, or mixtures thereof, acetic acid, water and ammonium aceta
4414149 Glycine.sup.8 -D-arginine.sup.24 calcitonin November 8, 1983
New peptides are disclosed which have biological activity of the same type as known calcitonins which have both a D-amino acid in position 24 instead of the natural L-amino acid and are substitution analogs of the natural calcitonins. Also resin peptides are disclosed which may be conver
4401593 Glycine - 8 calcitonin August 30, 1983
New peptides are disclosed which have biological activity of the same type as known calcitonins and which are substitution analogs of the natural calcitonins. Also resin peptides are disclosed which may be converted to peptides having such biological activity; and processes for producing
4397780 Leucine.sup.22 -calcitonin August 9, 1983
Two new peptides are disclosed which have biological activity of the same type as known calcitonins and which are substitution analogs of natural calcitonins. Also resin peptides are disclosed which may be converted to peptides having such biological activity; and processes for producing
4391747 Des asparagine-3-calcitonin July 5, 1983
Peptides are disclosed which have biological activity of the same type as known calcitonins and which have a shorter amino acid chain than natural calcitonins. Also resin peptides are disclosed which may be converted to peptides having such biological activity; and processes for producin
4388235 Synthesis of peptides June 14, 1983
New peptides are disclosed which have biological activity of the same type as known calcitonins and which have a shorter amino acid chain than natural calcitonins. Also resin peptides are disclosed which may be converted to peptides having such biological activity; and processes for
4385050 Antihypertensive polypeptides May 24, 1983
Peptides of the structurewhereinR.sub.1 is hydrogen, a peptide residue containing from 1 to 18 amino acid residues, or N-acyl, andR.sub.2 is hydrogen, an alcohol moiety of an ester, an amide, or a peptide residue containing from 1 to 10 amino acid residues,whereinthe acyl group is lower alka
4336187 Purification of calcitonin by partition chromatography June 22, 1982
The purification of crude calcitonin by subjecting a crude calcitonin material to partition chromatography in which the solvent utilized is a mixture of butanol, a lower alphatic alcohol which is ethanol, methanol, or propanol, or mixtures thereof, acetic acid, water and ammonium acetate
4304692 Synthesis of biologically active peptides December 8, 1981
A new peptide which has calcitonin-like biological activity which has a shorter amino acid chain and which is chemically more stable than natural calcitonins. Also resin peptides are disclosed which may be converted to peptides having biological activity and processes for producing said
4301045 Synthesis of peptides November 17, 1981
Resin peptides useful in the preparation of peptides having biological activity, and particularly such resin peptides containing Pro--Asp--CH.sub.2 -- or Pro--Asn--CH.sub.2 -- at one end of an amino acid chain, being the resin and Pro, Asp and Asn being the residues of the ami
4294826 Process for the preparation of highly purified antihemophilic factor October 13, 1981
An antihemophilic factor derived from human blood plasma, having about 1 to 10 units antihemophilic factor activity per mg of protein and being substantially free of denatured antihemophilic factor is prepared from material having 0.3 to 1.0 unit per mg of protein.
4228154 Purification of plasma albumin by ion exchange chromatography October 14, 1980
Purified plasma albumin is obtained by ion exchange chromatographic procedures and in the absence of process steps involving precipitation or desorption of the albumin.
4223010 Basic zirconium complexes and methods of making and using in antiperspirants September 16, 1980
Basic zirconium gels may be used to form complexes with conventional aluminum and/or zirconium antiperspirant systems. The freshly prepared basic zirconium gels provide both a buffer for the highly acidic aluminum-zirconium complexes and an additional source of zirconium as an active
4212795 Cyclization of peptides July 15, 1980
The synthesis of a disulfide cyclic peptide by preparing an intermediate peptide containing two cysteine moieties, each of which is protected by an n-alkylthio group, or when one of such moieties is in an amino terminal position, this one moiety may be protected by a cysteine group while
4151276 Method of suppressing gastric acid secretion by the oral administration of calcitonin April 24, 1979
A method of obtaining suppression of gastric acid secretion in a mammalian host by the oral administration of calcitonin to the host mammal, including man, to obtain the suppression of gastric acid secretion therein. The method is useful in the treatment of mammals having grastric or
4148812 Method of making basic zirconium-amino-acid gels April 10, 1979
Basic zirconium gels may be used to form complexes with conventional aluminum and/or zirconium antiperspirant systems. The freshly prepared basic zirconium gels provide both a buffer for the highly acidic aluminum-zirconium complexes and an additional source of zirconium as an active
4147766 Macrospherical particles of anti-perspirants April 3, 1979
A process and apparatus are provided for making hollow macrospherical particles. The particles themselves are particularly adapted for use as anti-perspirants. The particles have a diameter between about 10 and 74 microns, preferably predominating between 15 and 44 microns, and a greater
4137306 Anhydrous antiperspirant stick compositions January 30, 1979
Improved antiperspirant stick compositions are provided which comprise a substantially anhydrous, homogeneous mixture of an alcohol soluble astringent basic aluminum compound as the active ingredient in a solid or semi-solid system including an alkylene polyhydric alcohol, a normally
4130514 Synthesis of peptides December 19, 1978
Peptides having adrenocorticotropic hormone activity and resin peptides useful in preparation of such peptides, particularly such peptides having asparagine at the carboxyl end thereof and more particularly such peptides having from 19 to 25 amino acids in their amino acid chains. The in
4116824 Automated wet sieving apparatus September 26, 1978
An automated wet sieving apparatus and process are provided comprising a wetting liquid distributor which is coupled by eccentric disks to a motor which drives the distributor in an orbital path for supplying the liquid onto a sieve. Means are provided for creating alternating vacuum and
1 2

 
 
  Recently Added Patents
Memory device having collaborative filtering to reduce noise
Pyridyldiamido transition metal complexes, production and use thereof
Rapid glycopeptide optimization via neoglycosylation
Field device configuration system
Luggage
Electronic device
Asynchronous loading of scripts in web pages
  Randomly Featured Patents
Computer aided dispatch and locator cellular system
Cyclic demand steam supply system
Fan blade
Empirically based dynamic control of acceptance of victim cache lateral castouts
Method of fabricating a tank by joining wall sections with fiber reinforced joiner panels
Medical probe device and method
Case
Resilient packing ring and assembly
Apparatus for recirculation of liquids
Thermoplastic polyurethane derived from polytetramethylene carbonate diol